ATC Group: J01XE01 Nitrofurantoin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01XE01 in the ATC hierarchy

Level	Code	Title
`1`	J	Antiinfectives for systemic use
`2`	J01	Antibacterials for systemic use
`3`	J01X	Other antibacterials
`4`	J01XE	Nitrofuran derivatives
`5`	J01XE01	Nitrofurantoin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	0.2 g

Active ingredients in J01XE01

Active Ingredient
Nitrofurantoin
Nitrofurantoin is a broad spectrum antibacterial agent, active against the majority of urinary pathogens. It is bactericidal in renal tissue and throughout the urinary tract. The wide range of organisms sensitive to the bacterial activity include Escherichia coli, Enteroccus faecalis, Klebsiella species, Enterobacter species, Staphylococcus species: (e.g. S. aureus, S. saprophyticus, S. epidermidis).

Related product monographs

Document	Type	Information Source
MACROBID Capsule	MPI, US: SPL/Old	FDA, National Drug Code (US)
MACROBID Prolonged-release capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
MACRODANTIN Capsule	MPI, US: SPL/Old	FDA, National Drug Code (US)